Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation

v2.4.0.8
Equity-Based Compensation
12 Months Ended
Dec. 28, 2013
Equity-Based Compensation [Abstract]  
Equity-Based Compensation

NOTE – EQUITY-BASED COMPENSATION

 

Equity-based compensation expense for fiscal years 2011, 2012, and 2013 was $10,549,  $10,210, and $7,624, respectively.  The related tax benefit for these periods was $3,852,  $3,554, and $2,575, respectively. 

 

The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 28, 2012.  This table does not include an estimate for future grants that may be issued.

 

 

 

 

 

 

 

 

 

2014

 

$          5,948

2015

 

4,040 

2016

 

2,085 

2017

 

1,286 

2018

 

236 

 

 

$        13,595

 

 

 

The cost above is expected to be recognized over a weighted-average period of 1.9 years.

 

 

 

 

 

 

 

The Company’s 2006 Equity Incentive Award Plan (the “2006 Plan”) is currently the only plan under which equity awards are issued.  This plan allows for the grant of various equity awards, including stock-settled stock appreciation rights, stock options, deferred stock units, and other types of equity-based awards, to the Company’s officers, key employees, and non-employee directors. 

 

Since its inception 10,000 shares have been authorized under the 2006 Plan.  As of December 28, 2013, a total of 6,004 awards had been granted under the 2006 Plan, of which 5,882 were stock-settled stock appreciation rights, 8 were stock options, and 114 were deferred stock units.  Also, as of December 28, 2013, a total of 1,043 awards had been canceled and added back to the number of units available for issuance under the 2006 Plan.

 

The Company’s Compensation Committee utilizes two types of vesting methods when granting awards to officers and key employees under the 2006 Plan based upon the nature of the grant.  Awards granted to officers and key employees upon hire or promotion to such a position will generally vest 20% each year on the anniversary of the grant date and expire five and one-half years from the date of grant.  Awards granted as a supplement to existing equity awards held by officers and key employees will generally vest 50% each year beginning on the first grant date anniversary following the final vesting of previous grants.  These supplemental awards typically expire five and one-half years from the date of grant.  Awards of stock options and stock-settled stock appreciation rights to be granted to non-employee directors will generally vest 25% each quarter, commencing on the last day of the fiscal quarter in which the awards are granted, and will expire five years to five and one-half years from the date of grant.  Awards of deferred stock units are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates.

 

 

 

 

 

 

 

 

 

 

NOTE – EQUITY-BASED COMPENSATION – CONTINUED

 

The Company uses the Black-Scholes option pricing model to estimate the fair value of its equity awards.  The weighted-average fair value of stock-settled stock appreciation rights that were granted in 2011, 2012, and 2013 was $12.40,  $15.35, and $17.59, respectively.  Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of equity awards that were granted during the periods indicated.  Deferred stock units are full-value shares at the date of grant and have been excluded from the table below.

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

2011

 

2012

 

2013

 

 

 

 

 

 

 

Expected volatility (1)

 

56.0% 

 

50.7% 

 

41.9% 

Risk-free interest rate (2)

 

1.1% 

 

0.6% 

 

0.7% 

Expected life (3)

 

3.9 yrs.

 

3.9 yrs.

 

3.9 yrs.

Expected dividend yield (4)

 

0.0% 

 

0.0% 

 

0.0% 

Weighted-average grant price (5)

 

$
28.89 

 

$
39.41 

 

$
53.83 

 

 

 

 

 

 

 

(1) Through June, 2012 expected volatility was a weighted-average of historical volatility and implied volatility.

In July 2012, the Company eliminated the implied volatility aspect of this calculation and began utilizing

historical volatility alone.

 

 

 

 

 

 

(2) Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.

(3) For awards that follow the 20% per year vesting schedule, expected life is a weighted-average that includes

historical settlement data of the Company's equity awards and a hypothetical holding period for outstanding

awards.  Due to lack of historical settlement data on awards that follow the 50% vesting at each of years four

and five, expected life of these awards is calculated under the simplified method.

(4) The Company historically has not paid dividends.

(5) Grant price is the closing price of the Company's common stock on the date of grant.

 

 

 

 

 

 

 

 

A summary of the Company’s stock option and stock-settled stock appreciation right activity is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

Weighted-average exercise price

 

Weighted-average remaining contractual term

 

Aggregate intrinsic value*

 

Outstanding at December 29, 2012

 

2,689 

 

$          34.43

 

2.9 

 

$          5,136

 

Granted

 

175 

 

53.83 

 

 

 

 

 

Exercised

 

(939)

 

32.20 

 

 

 

 

 

Canceled

 

(98)

 

35.87 

 

 

 

 

 

Expired

 

 -

 

 -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 28, 2013

 

1,827 

 

$          37.37

 

2.6 

 

$        74,160

 

 

 

 

 

 

 

 

 

 

 

Exercisable at December 28, 2013

 

540 

 

$          35.73

 

1.8 

 

$        22,678

 

 

 

 

 

 

 

 

 

 

 

*   Aggregate intrinsic value is defined as the difference between the current market value at the reporting

 

 

 

date (the closing price of the Company's common stock on the last trading day of the period) and the

 

 

 

exercise price of awards that were in-the-money.  The closing price of the Company's common stock at

 

 

 

December 29, 2012 and December 28, 2013, was $31.60 and $77.72, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The total intrinsic value of stock options and stock-settled stock appreciation rights exercised was $925 in 2011, $20,590 in 2012, and $32,837 in 2013.  The Company currently has no deferred stock units that are considered nonvested.    

 

The total fair value of equity awards that vested during fiscal years 2011, 2012, and 2013 was $10,993, $10,211, and $8,096, respectively.  This total fair value includes equity-based awards issued in the form of stock options, stock-settled stock appreciation rights, and deferred stock units.